Advertisement

Liposomes — Further Considerations of Their Possible Role as Carriers of Therapeutic Agents

  • Brenda E. Ryman
  • Gillian M. Barratt
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 47)

Abstract

Liposomes, for many years a tool of the membranologists, have over the last 12 years been used in many other areas of research. Apart from their continuing use in membrane research, including immunological investigations, these phospholipid vesicles have found themselves the centre of attraction as possible carriers of materials of therapeutic interest.

Keywords

Therapeutic Index Tumour Weight Phospholipid Vesicle Anticancer Chemotherapy Human Colonic Tumour 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barratt, G.M., Ryman, B.E., Boden, J.A., Keep, P.A., Searle, F., Begent, R.H. and Bagshawe, K.D., 1981, Liposomal clearance of antibodies to tumour products: Possible improvement of tumour detection. Biochem. Soc. Trans. 9: in press.Google Scholar
  2. Begent, R.H., Stanway, G., Jones, B.E., Bagshawe, K.D., Searle, F., Jewkes, R.F. and Vernon, P., 1980, Radioimmunolocalization of tumours by external scintigraphy after administration of 1311 antibody to human chorionic gonadotrophin: preliminary communication, J. R. Soc. Med 73: 624.PubMedGoogle Scholar
  3. Campbell, P., Harding, N.G.L., Ryman, B.E. and Tyrrell, D.A., 1980, Redistribution and altered excretion of digoxin in rats receiving digoxin antibodies incorporated in liposomes, Eur. J. Biochem, 109: 87.PubMedCrossRefGoogle Scholar
  4. Goldenberg, D.M., Deland, F., Kim, E., Bennett, S., Primus, F.J., van Nagell, J.R., Estes, N., De Simone, P. and Rayburn, P., 1978, Use of radiolabelled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning, New Engl. J. Med, 298: 1384.PubMedCrossRefGoogle Scholar
  5. Gregoriadis, G., 1979, in: “Drug Carriers in Biology and Medicine,” G. Gregoriadis, ed., Academic Press, London and New York.Google Scholar
  6. Gregoriadis, G. and Ryman, B.E., 1972a, Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases, Eur. J. Biochem, 24: 485.PubMedCrossRefGoogle Scholar
  7. Gregoriadis, G. and Ryman, B.E., 1972b, Lysosomal localization of 8 fructofuranosidase-containing liposomes injected into rats: some implications in the treatment of genetic disorders. Biochem. J, 129: 123.PubMedGoogle Scholar
  8. Hunter, W.M. and Greenwood, F.C., 1962, Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature, 194: 495.PubMedCrossRefGoogle Scholar
  9. Kaye, S.B., Boden, J.A. and Ryman, B.E., 1981, The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours, Eur. J. Cancer, 17: 279.PubMedCrossRefGoogle Scholar
  10. Kosloski, M.J., Rosen, F., Milholland, R.J. and Papahadjopoulos, D., 1978, Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors, Cancer Res, 38: 28–48.Google Scholar
  11. Osborne, M.P., RYtpan, B.E., Payne, J.H. and McCready, V.R., 1981a, The use of 9 mTc-labelled neutral liposomes in lymphoscintigraphy: A comparison of scintigram interpretations with node histology in a series of breast cancer patients, in “Progress in Radiopharmacology” vol. 2, P.H. Cox, ed., Elsevier/NorthHolland Biomedical Press, Amsterdam.Google Scholar
  12. Osborne, M.P., Richardson, V.J., Jeyasingh, K. and Ryman, B.E., 1981b, Potential applications of radionuclide-labelled liposomes in the detection of the lymphatic spread of cancer, Int. J. Nucl. Med. Biol., submitted.Google Scholar
  13. Papahadjopoulos, D., Poste, G., Vail, W.J. and Biedler, J.L., 1976, Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumour cells, Cancer Res., 36: 2988.Google Scholar
  14. Richardson, V.J., Jeyasingh, K., Jewkes, R.F., Ryman, B.E. and Tattersall, M.H.N., 1978a, Possible localization of 99mTclabelled liposomes: Effects of lipid composition, charge and liposome size, J. Nucl. Med, 19: 1049.PubMedGoogle Scholar
  15. Richardson, V.J., Osborne, M.P., Jeyasingh, K., Ryman, B.E. and Burn, J.I., 1978b, Differential localization of (99mTc)technetium labelled liposomes in normal and tumour-bearing lymph nodes of the rat, Br. J. Cancer, 38: 177.Google Scholar
  16. Richardson, V.J., Ryman, B.E., Jewkes, R.F., Jeyasingh, K., Tattersall, M.H.N., Newlands, E.S. and Kaye, S.B., 1979, Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br. J. Cancer, 40: 35.PubMedCrossRefGoogle Scholar
  17. Rustum, Y.M., Dave, C., Mayhew, E. and Papahadjopoulos, D., 1979, Role of liposome type and route of adminsitration in the antitumor activity of liposome-entrapped 1 -D-arabinofuranosylcytosine against mouse L1210 leukaemia, Cancer Res, 39: 1390.PubMedGoogle Scholar
  18. Ryman, B.E., Jewkes, R.F., Jeyasingh, K., Osborne, M.P., Patel, H.M., Richardson, V.J., Tattersall, M.H.N. and Tyrrell, D.A., 1978, Potential applications of liposomes to therapy, Ann. N.Y. Acad. Sci, 308: 281.PubMedCrossRefGoogle Scholar
  19. Ryman, B.E. and Tyrrell, D.A., 1979, Liposomes - Methodology and Applications, in “Lysosomes in Biology and Pathology”, vol. 6, J.T. Dingle, P.J. Jacques and I.H. Shaw, eds., Elsevier/NorthHolland Biomedical Press, Amsterdam.Google Scholar
  20. Ryman, B.E. and Tyrrell, D.A., 1980, Liposomes - Bags of Potential, in: “Essays in Biochemistry” vol. 16, P.N. Campbell and R.D. Marshall, eds., Academic Press, London.Google Scholar
  21. Schwartz, H.S., Sodergren, J.E., Sternberg, S.S. and Philips, P.S., 1966, Actinomycin D: Effects of Ridgway osteogenic sarcoma in mice, Cancer Res, 26: 1873.PubMedGoogle Scholar
  22. Tyrrell, D.A., Campbell, P.I., Harding, N.G.L., Munroe, A. and Ryman, B.E., 1978, Antidigoxin antibody incorporation into liposomes - a potential therapy for digoxin toxicity, Biochem. Soc. Trans, 6: 1239.PubMedGoogle Scholar
  23. Tyrrell, D.A., Heath, T.D., Colley, C.M. and Ryman, B.E., 1976, New aspects of liposomes, Biochem. Biophys. Acta, 457: 259.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Brenda E. Ryman
    • 1
  • Gillian M. Barratt
    • 1
  1. 1.Department of Biochemistry, Charing Cross Hospital Medical SchoolUniversity of LondonHammersmith, LondonUK

Personalised recommendations